About Servier Pharmaceuticals

Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes.

Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year.

Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all.

See our community guidelines here: https://www.servier.us/community-guidelines

To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceuticals
location icon
Headquarter
200 Pier Four Boulevard, Boston, MA 02210, US
description icon
Founded
2018

Servier Pharmaceuticals Alternatives

Frequently Asked Questions about Servier Pharmaceuticals

Who is the CEO of Servier Pharmaceuticals?

Chadi Maroun is the CEO of Servier Pharmaceuticals. To contact Chadi Maroun email at [email protected].

Who are the decision makers in Servier Pharmaceuticals?

The decision makers in Servier Pharmaceuticals are Alaina Pleatman, David K Lee, Justin Cidado, etc. Click to Find Servier Pharmaceuticals decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more